Hypercalcemia is a condition defined by an elevated level of calcium in the blood. It is a common and potentially serious medical condition that can lead to various cardiac complications. Although the clinical significance of hypercalcemia has been recognized for many years, the underlying mechanisms of its cardiac effects remain elusive. This article will explore the hidden cardiac effects of hypercalcemia from an electrocardiogram (ECG) perspective.
Hypercalcemia is a condition characterized by an abnormally high level of calcium in the blood. It is most commonly caused by primary hyperparathyroidism, malignancy, or certain medications. The normal range of calcium in the blood is 8.5 to 10.5 mg/dL. Hypercalcemia is defined as a calcium level greater than 10.5 mg/dL.
The symptoms of hypercalcemia vary depending on the severity of the condition. Mild hypercalcemia may cause no symptoms at all, while more severe cases can lead to a wide range of symptoms, including: • Muscle weakness • Fatigue • Nausea • Vomiting • Confusion • Abdominal pain • Constipation • Increased thirst • Increased urination
Hypercalcemia can have a number of adverse effects on the heart, including arrhythmias, congestive heart failure, and myocardial infarction. The underlying mechanisms of these cardiac effects are not fully understood, but are thought to involve a combination of electrolyte abnormalities, calcium overload, and altered calcium metabolism.
The ECG is a valuable tool for diagnosing and monitoring hypercalcemia. ECG findings in hypercalcemia can include a prolonged QT interval, ST segment depression, T wave inversion, and atrial and ventricular arrhythmias. These findings can be subtle and may not be immediately apparent on a routine ECG.
QT interval prolongation is one of the most common ECG findings in hypercalcemia. The QT interval is the time between the start of the QRS complex and the end of the T wave. It is a measure of the time taken for the ventricles to depolarize and repolarize. Prolongation of the QT interval can lead to the development of torsades de pointes, a potentially life-threatening arrhythmia.
ST segment depression is another common ECG finding in hypercalcemia. ST segment depression is a downward deflection of the ST segment, which is the period between the end of the QRS complex and the beginning of the T wave. It is a marker of myocardial ischemia and can be seen in hypercalcemia due to the increased workload on the heart.
T wave inversion is another common ECG finding in hypercalcemia. T wave inversion is a downward deflection of the T wave, which is the period between the end of the QRS complex and the beginning of the T wave. It is a marker of myocardial ischemia and can be seen in hypercalcemia due to the increased workload on the heart.
Atrial and ventricular arrhythmias are common in hypercalcemia. These arrhythmias can be caused by electrolyte abnormalities, calcium overload, and altered calcium metabolism. Atrial arrhythmias such as atrial fibrillation and atrial flutter can be seen, as well as ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation.
Hypercalcemia is a common and potentially serious medical condition that can lead to a variety of cardiac complications. The underlying mechanisms of these cardiac effects are not fully understood, but are thought to involve a combination of electrolyte abnormalities, calcium overload, and altered calcium metabolism. The ECG is a valuable tool for diagnosing and monitoring hypercalcemia, and can be used to detect subtle changes in the heart such as QT interval prolongation, ST segment depression, and T wave inversion
1.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
2.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
5.
A garden can save your life
1.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
2.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
3.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation